IMPAIRED FASTING GLUCOSE IS THE MAJOR DETERMINANT OF THE 20-YEAR MORTALITY RISK ASSOCIATED WITH METABOLIC SYNDROME IN NON-DIABETIC PATIENTS WITH STABLE CORONARY ARTERY DISEASE